All NIH Funding Opportunities and Notices

• NIH Operates Under a Continuing Resolution Through February 8, 2018
  (NOT-OD-18-139)
  National Institutes of Health
  

• Notice of Change to Page Limits for Attachments to PAR-18-594 "NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)"
  (NOT-AR-18-015)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Change to Page Limits for Attachments to PAR-18-595, "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)"
  (NOT-AR-18-016)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Expiration of PAR-17-172 "Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24)"
  (NOT-AT-18-005)
  National Center for Complementary and Integrative Health
  

• Revision: Notice of Intent to Publish a Funding Opportunity Announcement for National Dental Practice-Based Research Network: Administrative and Resource Center (U19 Clinical Trial Required - Infrastructure )
  (NOT-DE-18-009)
  National Institute of Dental and Craniofacial Research
  

• Revision: Notice of Intent to Publish a Funding Opportunity Announcement for National Dental Practice-Based Research Network: Coordinating Center (U01 Clinical Trial Required - Infrastructure )
  (NOT-DE-18-010)
  National Institute of Dental and Craniofacial Research
  

• Notice of Update to the Application Instructions for PAR-18-108 NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
  (NOT-DK-18-010)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change to Receipt Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (NOT-EB-18-005)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Notice of Participation of the NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  (NOT-EB-18-006)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice of Clarification for AIDS Dates for RFA-HL-17-015 "Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)"
  (NOT-HL-18-582)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Instructions for Application Submission for RFA-HL-19-001 "Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed)"
  (NOT-HL-18-593)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Instructions for Application Submission for RFA-HL-19-002 "Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)"
  (NOT-HL-18-594)
  National Heart, Lung, and Blood Institute
  

• AHRQ Notice of Extension of PA-15-179 and PA-15-180
  (NOT-HS-18-004)
  Agency for Healthcare Research and Quality
  

• Notice of NCATS Participation in PA-18-592 "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)"
  (NOT-TR-18-018)
  National Center for Advancing Translational Sciences
  

• Notice of Change in Key Dates for PAR-17-001 "Emerging Global Leader Award (K43)"
  (NOT-TW-18-003)
  John E. Fogarty International Center
  National Cancer Institute
  National Human Genome Research Institute
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  

• Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required)
  (RFA-AG-18-030)
  National Institute on Aging
  Application Receipt Date(s): April 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• Consortia for HIV/AIDS Vaccine Development (CHAVD) (UM1 Clinical Trial Not Allowed)
  (RFA-AI-18-001)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 28, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• NIAMS Skin Biology and Diseases Resource-based Centers (P30 Clinical Trial Not Allowed)
  (RFA-AR-19-001)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): June 11, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• NIAMS Musculoskeletal Biology and Medicine Resource-based Centers (P30 Clinical Trial Not Allowed)
  (RFA-AR-19-002)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): June 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  

• Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (U01 Clinical Trial Not Allowed )
  (RFA-DK-17-511)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 26, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• Revolutionizing Innovative, Visionary Environmental health Research (RIVER) (R35 Clinical Trial Not Allowed)
  (RFA-ES-18-004)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): June 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)
  (RFA-MD-18-006)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Application Receipt Date(s): April 16, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  

• NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional)
  (RFA-MH-19-130)
  National Institute of Mental Health
  Application Receipt Date(s): June 20, 2018 and June 20, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  

• Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed)
  (RFA-NS-18-015)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  

• Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed)
  (RFA-NS-18-024)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  

• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
  (PA-18-629)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
  (PA-18-631)
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  
  

• NIDA Small Research Grant Program (R03 Clinical Trial Required)
  (PA-18-634)
  National Institute on Drug Abuse
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional)
  (PA-18-635)
  National Eye Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 25, 2018.
  
  

• NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
  (PA-18-642)
  National Institute of Mental Health
  Application Receipt Date(s): NIMH accepts and reviews applications on a continuous basis until April 1 of each fiscal year. Applications received after April 1 will be considered for funding in the next fiscal year. Earlier submission is strongly encouraged. Applications for FY 18 funds should be submitted no later than April 1, 2018. Applications for FY 19 funds should be submitted no later than April 1, 2019. Applications for FY 20 funds should be submitted no later than April 1, 2020 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional)
  (PA-18-647)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): July 1, 2018; March 1, 2019, July 1, 2019, March 1 2020, July 1, 2020, March 1, 2021 by 5:00 PM local time of applicant organization.
  
  

• NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
  (PA-18-648)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Office of the Director, NIH
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Office of Strategic Coordination (Common Fund)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
  (PAR-18-628)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
  
  

• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
  (PAR-18-630)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  National Institute of General Medical Sciences
  Application Receipt Date(s): April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
  (PAR-18-632)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021, by 5:00 PM local time of applicant organization.
  
  

• NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
  (PAR-18-633)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 14, 2018; September 13, 2018; January 14, 2019; May 13, 2019; September 13, 2019; January 13, 2020; May 13, 2020; September 14, 2020; January 13, 2021), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional)
  (PAR-18-638)
  National Cancer Institute
  Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional)
  (PAR-18-639)
  National Cancer Institute
  Application Receipt Date(s): June 13, 2018; October 11, 2018, June 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
  (PAR-18-640)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
  (PAR-18-641)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
  (PAR-18-643)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): April 30, 2018, August 24, 2018, December 18, 2018, April 30, 2019, August 24, 2019, December 18, 2019, April 30, 2020, August 24, 2020, and December 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)
  (PAR-18-644)
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
  
  

• Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
  (PAR-18-645)
  National Institute on Aging
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for resubmission and revision applications is March 16, 2018. The first standard due date for new applications is June 16, 2018.
  
  

• Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional)
  (PAR-18-646)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Dietary Supplements
  Office of Research on Women's Health
  Application Receipt Date(s): April 11, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  
  

• Human-Animal Interaction (HAI) Research (R03 - Clinical Trial Optional)
  (PAR-18-649)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Human-Animal Interaction (HAI) Research (R21 - Clinical Trial Optional)
  (PAR-18-650)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892